Radhakrishnan Pillai, PhD

Article

Safety and Efficacy of Halobetasol Propionate Lotion 0.01% in the Treatment of Moderate to Severe Plaque Psoriasis: A Pooled Analysis of 2 Phase 3 Studies

Author:

Jeffrey L. Sugarman, MD, PhD

Jonathan S. Weiss, MD

Emil A. Tanghetti, MD

Jennifer Soung, MD

Paul S. Yamauchi, MD

Tina Lin, PharmD

Susan Harris, MS

Gina Martin, MOT

Radhakrishnan Pillai, PhD

Potent topical corticosteroids are the mainstay of psoriasis treatment, but safety concerns have limited use to 2 to 4 weeks. This study...

• Read More